Sponsor pipeline

The First Affiliated Hospital of Zhengzhou University clinical trial pipeline

Get alerts when The First Affiliated Hospital of Zhengzhou University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

  1. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-18 NCT07828873 A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally… Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 1/2
3
Phase 2
24
Phase 3
3
Phase 4
1
Not charted: 22 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 54

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06930573 A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular… HCC Recruiting 2025-04-16
Phase 3
NCT07617870 Pro-urokinase for Extended-Window Posterior Circulation Stroke Acute Ischemic Stroke Not Yet Recruiting 2026-06-01
NCT07540416 Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch Acute Ischemic Stroke Not Yet Recruiting 2026-04-20
NCT07446335 A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With… Advanced Esophageal Squamous Cell Carcinoma Not Yet Recruiting 2026-03-03
Phase 2
NCT07294664 PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line… Advanced Gastric Cancer Recruiting 2026-09-01
NCT07770113 A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With… GC/GEJC Recruiting 2026-08-18
NCT07104149 Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer Female, Age ≥ 18 Years Old Recruiting 2025-08-05
NCT07016724 Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal… Esophageal Squamous Cell Carcinoma Recruiting 2025-06-12
NCT06557161 A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT… Acute Lymphoblastic Leukemia, Adult Recruiting 2025-02-18
NCT06559345 A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of… Acute Lymphoblastic Leukemia, Pediatric Recruiting 2025-02-18
NCT06564493 A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT… Acute Lymphoblastic Leukemia, Pediatric Recruiting 2025-02-18
NCT06564545 A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of… Acute Lymphoblastic Leukemia, Adult Recruiting 2025-02-18
NCT06718205 Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous… Esophageal Cancer Recruiting 2024-12-05
NCT05738434 Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for… Esophageal Cancer by AJCC V8 Stage Recruiting 2024-11-21
NCT05286957 MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC NSCLC Recruiting 2023-03-17
NCT05182944 A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With… Esophageal Cancer Recruiting 2022-05-11
NCT07828873 A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally… Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Not Yet Recruiting 2026-09-18
NCT07814859 Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line… Pancreatic Cancer Not Yet Recruiting 2026-09-11
NCT07314619 Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety… Platinum-resistant Recurrent Ovarian Cancer (PROC) Not Yet Recruiting 2026-01-02
NCT07128693 A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy… Esophageal Squamous Cell Carcinoma Not Yet Recruiting 2025-08-19
NCT07085273 Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of… Gastric Cancer Not Yet Recruiting 2025-07-31
NCT06901622 Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for… Gallbladder Cancer and Extrahepatic Cholangiocarcinoma Enrolling by Invitation 2025-03-30
NCT06760520 Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal… Locally Advanced Rectal Cancer Not Yet Recruiting 2025-01-08
NCT06492317 RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer HER2-positive Gastric Cancer Not Yet Recruiting 2024-07-09
NCT06439550 Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC HER2-positive Gastric Cancer Not Yet Recruiting 2024-06-03
See all 54 active The First Affiliated Hospital of Zhengzhou University trials with filters →

Disease areas by active trials, top 10 of 17

Esophageal Cancer (8) · Glioma (6) · Gastric Cancer (5) · Acute Lymphoblastic Leukemia (ALL) (4) · Colorectal Cancer (4) · Leukemia (4) · Stroke (4) · HER2-Positive Cancer (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2)

Get alerts when The First Affiliated Hospital of Zhengzhou University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free